↓ Skip to main content

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase…

Overview of attention for article published in Frontiers in Cardiovascular Medicine, June 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
Published in
Frontiers in Cardiovascular Medicine, June 2023
DOI 10.3389/fcvm.2023.1177166
Pubmed ID
Authors

Shuyang Zhang, Ying Li, Xin Xu, Rui Xu, Linchao Zhang, Xiaoqun Wan, Zhuhua Yao, Yuemin Sun, Yong Liu, Jianping Bin, Zhen Wang, Shuren Li, Ping Yang, Xiping Xu, Weidong Liang, Xiaohong Gao, Xiaodong Li, Min Jia, Guang Ma, Xiang Gu, Chang Hong

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 2 29%
Unknown 5 71%
Readers by discipline Count As %
Nursing and Health Professions 1 14%
Social Sciences 1 14%
Unknown 5 71%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2023.
All research outputs
#21,396,838
of 23,885,338 outputs
Outputs from Frontiers in Cardiovascular Medicine
#4,754
of 7,851 outputs
Outputs of similar age
#137,594
of 166,804 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#101
of 303 outputs
Altmetric has tracked 23,885,338 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,851 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,804 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 303 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.